Sequana Medical 获得 400 万欧元贷款和高达 6000 万欧元的资金，用于 alfapump® US 的启动。 Sequana Medical secures €4 million loan and up to €60 million in funding for alfapump® US launch.

Sequana Medical 是一家专门从事液体超负荷治疗的公司，已从其主要股东那里获得了 400 万欧元的可转换贷款，并从 GEM Global Yield LLC SCS 获得了高达 6000 万欧元的潜在资金。 Sequana Medical, a company specializing in fluid overload treatments, has received a EUR 4.0 million convertible loan from its major shareholders and up to EUR 60 million in potential funding from GEM Global Yield LLC SCS. 这笔融资将使公司的现金跑道延长至 2025 年底，与预计在 FDA 批准后于 2025 年年中在美国推出其 alfapump® 设备相一致。 This financing will extend the company's cash runway to the end of 2025, aligning with the anticipated US launch of its alfapump® device in mid-2025, following FDA approval.